Melanie Quintana

1.4k total citations
19 papers, 611 citations indexed

About

Melanie Quintana is a scholar working on Statistics and Probability, Molecular Biology and Epidemiology. According to data from OpenAlex, Melanie Quintana has authored 19 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Statistics and Probability, 5 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Melanie Quintana's work include Statistical Methods in Clinical Trials (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Hepatitis C virus research (4 papers). Melanie Quintana is often cited by papers focused on Statistical Methods in Clinical Trials (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Hepatitis C virus research (4 papers). Melanie Quintana collaborates with scholars based in United States, United Kingdom and Australia. Melanie Quintana's co-authors include Scott Berry, Kristine Broglio, Donald A. Berry, Christine Brezden‐Masley, Alexander Paterson, Jean-François Boileau, Anna McGlothlin, Susan Dent, Daniel Rayson and Karen A. Gelmon and has published in prestigious journals such as Neurology, Annals of Neurology and Journal of Hepatology.

In The Last Decade

Melanie Quintana

19 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melanie Quintana United States 10 178 177 128 90 88 19 611
Jenny J. Zhang United States 17 172 1.0× 81 0.5× 43 0.3× 81 0.9× 285 3.2× 28 963
William B. Wong United States 16 299 1.7× 192 1.1× 68 0.5× 36 0.4× 115 1.3× 65 892
Jean Abraham United Kingdom 16 398 2.2× 236 1.3× 46 0.4× 25 0.3× 214 2.4× 40 896
Suna Barlas United States 10 164 0.9× 61 0.3× 95 0.7× 8 0.1× 205 2.3× 13 845
Zhao Yang China 15 313 1.8× 80 0.5× 25 0.2× 54 0.6× 113 1.3× 66 820
Yongqiang Tang United States 16 102 0.6× 21 0.1× 41 0.3× 157 1.7× 77 0.9× 44 567
Takashi Imamoto Japan 24 255 1.4× 175 1.0× 22 0.2× 40 0.4× 361 4.1× 64 1.5k
Angela Men United States 8 206 1.2× 25 0.1× 48 0.4× 20 0.2× 125 1.4× 12 597
Tony Sabin United Kingdom 10 70 0.4× 26 0.1× 51 0.4× 60 0.7× 184 2.1× 11 349

Countries citing papers authored by Melanie Quintana

Since Specialization
Citations

This map shows the geographic impact of Melanie Quintana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Quintana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Quintana more than expected).

Fields of papers citing papers by Melanie Quintana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Quintana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Quintana. The network helps show where Melanie Quintana may publish in the future.

Co-authorship network of co-authors of Melanie Quintana

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Quintana. A scholar is included among the top collaborators of Melanie Quintana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Quintana. Melanie Quintana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Waser, Nathalie, Melanie Quintana, Bernd Schweikert, et al.. (2024). Pathological response in resectable non–small cell lung cancer: a systematic literature review and meta-analysis. JNCI Cancer Spectrum. 8(3). 6 indexed citations
2.
Quintana, Melanie, Benjamin R. Saville, Michelle A. Detry, et al.. (2023). Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral Sclerosis. Annals of Neurology. 94(3). 547–560. 19 indexed citations
3.
Paganoni, Sabrina, et al.. (2023). Analysis of sodium phenylbutyrate and taurursodiol survival effect in ALS using external controls. Annals of Clinical and Translational Neurology. 10(12). 2297–2304. 12 indexed citations
4.
Matejcic, Marco, Melanie Quintana, Fredrick R. Schumacher, et al.. (2021). Rare Variants in the DNA Repair Pathway and the Risk of Colorectal Cancer. Cancer Epidemiology Biomarkers & Prevention. 30(5). 895–903. 4 indexed citations
5.
Paganoni, Sabrina, James D. Berry, Melanie Quintana, et al.. (2021). Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development. Annals of Neurology. 91(2). 165–175. 46 indexed citations
6.
7.
Carrillo, Nuria, Marjan Huizing, Petcharat Leoyklang, et al.. (2019). Open-Label Phase 2 Clinical Trial of ManNAc for GNE Myopathy (S23.008). Neurology. 92(15_supplement). 1 indexed citations
8.
Wagner, Kathryn R., Linda Cripe, Francesco Muntoni, et al.. (2019). EP.83Design of a Phase 2/3 randomized controlled trial of suvodirsen (WVE-210201) in patients with Duchenne muscular dystrophy amenable to exon 51 skipping. Neuromuscular Disorders. 29. S176–S177. 1 indexed citations
9.
Quintana, Melanie, Joseph A. Shrader, Christina Slota, et al.. (2018). Bayesian model of disease progression in GNE myopathy. Statistics in Medicine. 38(8). 1459–1474. 19 indexed citations
10.
Wang, Guoqiao, Scott Berry, Chengjie Xiong, et al.. (2018). A novel cognitive disease progression model for clinical trials in autosomal‐dominant Alzheimer's disease. Statistics in Medicine. 37(21). 3047–3055. 27 indexed citations
11.
Brown, Alexandra R., Byron J. Gajewski, Lauren S. Aaronson, et al.. (2016). A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization. Trials. 17(1). 428–428. 17 indexed citations
12.
Broglio, Kristine, Melanie Quintana, Margaret Foster, et al.. (2016). Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes. JAMA Oncology. 2(6). 751–751. 229 indexed citations
13.
Bateman, Randall J., Tammie L.S. Benzinger, Scott Berry, et al.. (2016). The DIAN‐TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model. Alzheimer s & Dementia. 13(1). 8–19. 176 indexed citations
14.
Quintana, Melanie, et al.. (2016). A Bayesian adaptive phase 1 design to determine the optimal dose and schedule of an adoptive T-cell therapy in a mixed patient population. Contemporary Clinical Trials. 48. 153–165. 8 indexed citations
15.
Gajewski, Byron J., Scott Berry, Melanie Quintana, et al.. (2015). Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spot. Statistics in Medicine. 34(7). 1134–1149. 17 indexed citations
16.
Broglio, Kristine, Eric S. Daar, Melanie Quintana, et al.. (2015). A meta-analysis platform methodology for determining the comparative effectiveness of antihepatitis C virus regimens. Journal of Comparative Effectiveness Research. 4(2). 101–114. 2 indexed citations
17.
Broglio, Kristine, Melanie Quintana, Eric S. Daar, et al.. (2014). Determining Comparative Effectiveness Benchmarks for Emerging Treatments for Hepatitis C Virus (Hcv) Infection in the Single Arm Study Design Setting. Value in Health. 17(3). A2–A2. 2 indexed citations
18.
McEwan, Phil, Thomas Ward, Yong Yuan, et al.. (2014). Estimating the Long-Term Clinical and Economic Outcomes of Daclatasvir Plus Asunaprevir in Difficult-to-Treat Japanese Patients Chronically Infected with Hepatitis C Genotype 1b. Value in Health Regional Issues. 3. 136–145. 14 indexed citations
19.
Quintana, Melanie, Eric S. Daar, Yuping Yuan, et al.. (2014). P1144 DETERMINING THE COMPARATIVE EFFECTIVENESS OF EMERGING TREATMENT REGIMENS FOR HEPATITIS C VIRUS (HCV) INFECTION FROM SINGLE ARM PHASE III TRIALS. Journal of Hepatology. 60(1). S463–S464. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jenny J. Zhang Breakdown of academic impact, for papers by William B. Wong Breakdown of academic impact, for papers by Jean Abraham Breakdown of academic impact, for papers by Suna Barlas Breakdown of academic impact, for papers by Zhao Yang Breakdown of academic impact, for papers by Yongqiang Tang Breakdown of academic impact, for papers by Takashi Imamoto Breakdown of academic impact, for papers by Angela Men Breakdown of academic impact, for papers by Tony Sabin
Rankless by CCL
2026